CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 453361-453518 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T51099","span":{"begin":0,"end":157},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We suggest that the level of anti-Ga4Ga antibodies is a specific biomarker for RRMS, with potential clinical utility for MS prognosis and disease management."}

{"project":"Epistemic_Statements","denotations":[{"id":"T952","span":{"begin":0,"end":157},"obj":"Epistemic_statement"}],"text":"We suggest that the level of anti-Ga4Ga antibodies is a specific biomarker for RRMS, with potential clinical utility for MS prognosis and disease management."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T199","span":{"begin":0,"end":157},"obj":"Sentence"}],"text":"We suggest that the level of anti-Ga4Ga antibodies is a specific biomarker for RRMS, with potential clinical utility for MS prognosis and disease management."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3097","span":{"begin":79,"end":83},"obj":"Disease"},{"id":"T3098","span":{"begin":121,"end":123},"obj":"Disease"},{"id":"T19512","span":{"begin":79,"end":83},"obj":"Disease"},{"id":"T75719","span":{"begin":121,"end":123},"obj":"Disease"}],"attributes":[{"id":"A3097","pred":"mondo_id","subj":"T3097","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A3098","pred":"mondo_id","subj":"T3098","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A94505","pred":"mondo_id","subj":"T19512","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A88668","pred":"mondo_id","subj":"T75719","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"We suggest that the level of anti-Ga4Ga antibodies is a specific biomarker for RRMS, with potential clinical utility for MS prognosis and disease management."}